Meanwhile, co-treatment of Rp1 and ActD also decreased AKT activation to downregulate the expression of SIRT1, and ultimately activated cells apoptosis as well as reversed chemoresistance in tumor cells. The gene discussed is RP1; the disease is neoplasm.